E-Plexx by Organixx — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
50% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

50% Evidence Coverage

Supplement Facts — Evidence Check

Magnesium

20 mg (5% DV)

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)

This product: 20mg

Organixx E-Plexx Blend

1150 mg

Other Ingredients

organic sprouted fermented Purple Maize Plant Cellulose organic Apple Cider Vinegar powder

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Organic Adult Female (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested use: Adults take two capsules daily with 8 ounces of water or juice.

⚠️ Warnings & Precautions

Caution: As with any dietary supplement, consult your healthcare practitioner before using this product, especially if you are pregnant, nursing, or are otherwise under medical supervision.

Do not use if product has been opened or tampered with in any way.

Keep out of reach of children.

🧪 Formulation Notes

Northeast Organic Farming Association of New York NOFA-NY Certified Organic LLC www.NOFANY.org

Maintain estrogen & balanced hormones Youth recapturing and anti-aging Skin health and beauty from within Supports metabolism and tranquility

Non-GMO Gluten free Soy free

Certified Organic by NOFA-NY, LLC.

Additional Information

Northeast Organic Farming Association of New York NOFA-NY Certified Organic LLC www.NOFANY.org

Product Details

UPC / SKU 8 51335 00716 1

DSLD Entry Date 2021-10-22

Product Type Other Combinations

Form Capsule

Brand Organixx

DSLD ID 256429

Data Updated 2026-04-11

Research Evidence

849 Research Sources

56 Avg Quality Score

450 Meta Analysis

152 Rct

137 Systematic Review

73 Clinical Trial

11 Regulatory Source

7 Other

7 Guideline

3 Openfda Safety

2 Cochrane Review

2 Observational

A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI Cochrane

A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes

Meta Analysis The Cochrane database of systematic reviews 2024

PubMed DOI Cochrane

A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life

Meta Analysis The Cochrane database of systematic reviews 2018

PubMed DOI Cochrane

A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

Meta Analysis The Cochrane database of systematic reviews 2025

PubMed DOI Cochrane

A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps

Systematic Review The Cochrane database of systematic reviews 2008

PubMed DOI Cochrane

A Calcium and vitamin D for increasing bone mineral density in premenopausal women

Systematic Review The Cochrane database of systematic reviews 2023

PubMed DOI Cochrane

A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis

Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019

PubMed DOI

A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis

Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021

PubMed DOI

A Calcium channel blockers versus other classes of drugs for hypertension

Systematic Review The Cochrane database of systematic reviews 2021

PubMed DOI

View all evidence for Electrolytes →